Involvement of potassium channels in the progression of cancer to a more malignant phenotype

Biochimica et Biophysica Acta - Biomembranes

Volumn 1848, Issue 10, 2015, Pages 2477-2492

  Comes, Nuria ^a   Serrano Albarrás, Antonio ^a   Capera, Jesusa ^a   Serrano Novillo, Clara ^a   Condom, Enric ^b   Ramón Y Cajal, Santiago ^c   Ferreres, Joan Carles ^c   Felipe, Antonio ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^c HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Cancer; Metastasis; Potassium channel; Tumorigenesis

Indexed keywords

POTASSIUM CHANNEL; POTASSIUM CHANNEL HEAG1; POTASSIUM CHANNEL HERG1; POTASSIUM CHANNEL KV1.3; POTASSIUM CHANNEL KV1.5; POTASSIUM CHANNEL TASK 1; POTASSIUM CHANNEL TASK 3; POTASSIUM CHANNEL TERK 1; UNCLASSIFIED DRUG; CALCIUM ACTIVATED POTASSIUM CHANNEL; POTASSIUM; POTASSIUM CHANNEL BLOCKING AGENT; TANDEM PORE DOMAIN POTASSIUM CHANNEL; VOLTAGE GATED POTASSIUM CHANNEL;

APOPTOSIS; CANCER GRADING; CARCINOGENESIS; CELL ADHESION; CELL CYCLE REGULATION; CELL INVASION; CELL MEMBRANE POTENTIAL; CELL MIGRATION; CELL PROLIFERATION; CELL VOLUME; CHANNEL GATING; HUMAN; MALIGNANT TRANSFORMATION; METASTASIS; NONHUMAN; POTASSIUM CELL LEVEL; POTASSIUM CURRENT; POTASSIUM TRANSPORT; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; TUMOR GROWTH; TUMOR MICROENVIRONMENT; TUMOR VASCULARIZATION; ANTAGONISTS AND INHIBITORS; CELL MOTION; CELL SIZE; DISEASE COURSE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; MEMBRANE POTENTIAL; METABOLISM; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PATHOLOGY; PHENOTYPE; VASCULARIZATION;

APOPTOSIS; CELL MOVEMENT; CELL PROLIFERATION; CELL SIZE; DISEASE PROGRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MEMBRANE POTENTIALS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PHENOTYPE; POTASSIUM; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS, CALCIUM-ACTIVATED; POTASSIUM CHANNELS, TANDEM PORE DOMAIN; POTASSIUM CHANNELS, VOLTAGE-GATED;

EID: 84941178312     PISSN: 00052736     EISSN: 18792642     Source Type: Journal    
DOI: 10.1016/j.bbamem.2014.12.008     Document Type: Review

References (286)

1. B. Hille Ion Channels of Excitable Membranes 3rd ed. 2001 Sinauer Sunderland, Mass
2. Z.A. McCrossan, and G.W. Abbott The MinK-related peptides Neuropharmacology 47 2004 787 821
3. B.A. Niemeyer, L. Mery, C. Zawar, A. Suckow, F. Monje, L.A. Pardo, W. Stuhmer, V. Flockerzi, and M. Hoth Ion channels in health and disease. 83rd Boehringer Ingelheim Fonds International Titisee Conference EMBO Rep. 2 2001 568 573
4. S.M. O'Grady, and S.Y. Lee Molecular diversity and function of voltage-gated (Kv) potassium channels in epithelial cells Int. J. Biochem. Cell Biol. 37 2005 1578 1594
5. T.E. DeCoursey, K.G. Chandy, S. Gupta, and M.D. Cahalan Voltage-gated K + channels in human T lymphocytes: a role in mitogenesis? Nature 307 1984 465 468
6. C.C. Shieh, M. Coghlan, J.P. Sullivan, and M. Gopalakrishnan Potassium channels: molecular defects, diseases, and therapeutic opportunities
7. Wang H.,Zhang Y.,Cao L.,Han H.,Wang J.,Yang B.,Nattel S.,Wang Z.,HERG K + channel, a regulator of tumor cell apoptosis and proliferation Cancer Res. 2002 62 4843-4848
8. Z. Wang Roles of K + channels in regulating tumour cell proliferation and apoptosis Pflugers Arch. 448 2004 274 286
9. L.A. Pardo Voltage-gated potassium channels in cell proliferation Physiology (Bethesda) 19 2004 285 292
10. K. Kunzelmann Ion channels and cancer J. Membr. Biol. 205 2005 159 173
11. M. Lan, Y. Shi, Z. Han, Z. Hao, Y. Pan, N. Liu, C. Guo, L. Hong, J. Wang, T. Qiao, and D. Fan Expression of delayed rectifier potassium channels and their possible roles in proliferation of human gastric cancer cells Cancer Biol. Ther. 4 2005 1342 1347
12. W. Zhanping, P. Xiaoyu, C. Na, W. Shenglan, and W. Bo Voltage-gated K + channels are associated with cell proliferation and cell cycle of ovarian cancer cell Gynecol. Oncol. 104 2007 455 460
13. S.H. Jang, S.Y. Choi, P.D. Ryu, and S.Y. Lee Anti-proliferative effect of Kv1.3 blockers in A549 human lung adenocarcinoma in vitro and in vivo Eur. J. Pharmacol. 651 2011 26 32
14. W.F. Wonderlin, and J.S. Strobl Potassium channels, proliferation and G1 progression J. Membr. Biol. 154 1996 91 107
15. J. Camacho Ether a go-go potassium channels and cancer Cancer Lett. 233 2006 1 9
16. M. Conti Targeting K + channels for cancer therapy J. Exp. Ther. Oncol. 4 2004 161 166
17. L.A. Pardo, C. Contreras-Jurado, M. Zientkowska, F. Alves, and W. Stuhmer Role of voltage-gated potassium channels in cancer J. Membr. Biol. 205 2005 115 124
18. F.M. Ashcroft From molecule to malady Nature 440 2006 440 447
19. N. Villalonga, J.C. Ferreres, J.M. Argiles, E. Condom, and A. Felipe Potassium channels are a new target field in anticancer drug design Recent Pat. Anticancer Drug Discov. 2 2007 212 223
20. J.Y. Le Guennec, H. Ouadid-Ahidouch, O. Soriani, P. Besson, A. Ahidouch, and C. Vandier Voltage-gated ion channels, new targets in anti-cancer research Recent Pat. Anticancer Drug Discov. 2 2007 189 202
21. W. Stuhmer, F. Alves, F. Hartung, M. Zientkowska, and L.A. Pardo Potassium channels as tumour markers FEBS Lett. 580 2006 2850 2852
22. A. Felipe, R. Vicente, N. Villalonga, M. Roura-Ferrer, R. Martinez-Marmol, L. Sole, J.C. Ferreres, and E. Condom Potassium channels: new targets in cancer therapy Cancer Detect. Prev. 30 2006 375 385
23. M. Abdul, and N. Hoosein Expression and activity of potassium ion channels in human prostate cancer Cancer Lett. 186 2002 99 105
24. M. Abdul, and N. Hoosein Voltage-gated potassium ion channels in colon cancer Oncol. Rep. 9 2002 961 964
25. K.W. Chang, T.C. Yuan, K.P. Fang, F.S. Yang, C.J. Liu, C.S. Chang, and S.C. Lin The increase of voltage-gated potassium channel Kv3.4 mRNA expression in oral squamous cell carcinoma J. Oral Pathol. Med. 32 2003 606 611
26. L. Bianchi, B. Wible, A. Arcangeli, M. Taglialatela, F. Morra, P. Castaldo, O. Crociani, B. Rosati, L. Faravelli, M. Olivotto, and E. Wanke herg encodes a K + current highly conserved in tumors of different histogenesis: a selective advantage for cancer cells? Cancer Res. 58 1998 815 822
27. R. Meyer, and S.H. Heinemann Characterization of an eag-like potassium channel in human neuroblastoma cells J. Physiol. 508 Pt 1 1998 49 56
28. L.M. Farias, D.B. Ocana, L. Diaz, F. Larrea, E. Avila-Chavez, A. Cadena, L.M. Hinojosa, G. Lara, L.A. Villanueva, C. Vargas, E. Hernandez-Gallegos, I. Camacho-Arroyo, A. Duenas-Gonzalez, E. Perez-Cardenas, L.A. Pardo, A. Morales, L. Taja-Chayeb, J. Escamilla, C. Sanchez-Pena, and J. Camacho Ether a go-go potassium channels as human cervical cancer markers Cancer Res. 64 2004 6996 7001
29. L.A. Pardo, D. del Camino, A. Sanchez, F. Alves, A. Bruggemann, S. Beckh, and W. Stuhmer Oncogenic potential of EAG K(+) channels EMBO J. 18 1999 5540 5547
30. C.S. Ortiz, D. Montante-Montes, M. Saqui-Salces, L.M. Hinojosa, A. Gamboa-Dominguez, E. Hernandez-Gallegos, B. Martinez-Benitez, M. Del Rosario Solis-Pancoatl, E. Garcia-Villa, A. Ramirez, R. Aguilar-Guadarrama, P. Gariglio, L.A. Pardo, W. Stuhmer, and J. Camacho Eag1 potassium channels as markers of cervical dysplasia Oncol. Rep. 26 2011 1377 1383
31. D. Mu, L. Chen, X. Zhang, L.H. See, C.M. Koch, C. Yen, J.J. Tong, L. Spiegel, K.C. Nguyen, A. Servoss, Y. Peng, L. Pei, J.R. Marks, S. Lowe, T. Hoey, L.Y. Jan, W.R. McCombie, M.H. Wigler, and S. Powers Genomic amplification and oncogenic properties of the KCNK9 potassium channel gene Cancer Cell 3 2003 297 302
32. S. Bittner, T. Budde, H. Wiendl, and S.G. Meuth From the background to the spotlight: TASK channels in pathological conditions Brain Pathol. 20 2010 999 1009
33. A.J. Patel, and M. Lazdunski The 2P-domain K + channels: role in apoptosis and tumorigenesis Pflugers Arch. 448 2004 261 273
34. H. Lallet-Daher, M. Roudbaraki, A. Bavencoffe, P. Mariot, F. Gackiere, G. Bidaux, R. Urbain, P. Gosset, P. Delcourt, L. Fleurisse, C. Slomianny, E. Dewailly, B. Mauroy, J.L. Bonnal, R. Skryma, and N. Prevarskaya Intermediate-conductance Ca2+-activated K + channels (IKCa1) regulate human prostate cancer cell proliferation through a close control of calcium entry Oncogene 28 2009 1792 1806
35. Z.H. Wang, B. Shen, H.L. Yao, Y.C. Jia, J. Ren, Y.J. Feng, and Y.Z. Wang Blockage of intermediate-conductance-Ca(2 +)-activated K(+) channels inhibits progression of human endometrial cancer Oncogene 26 2007 5107 5114
36. X.W. Yang, J.W. Liu, R.C. Zhang, Q. Yin, W.Z. Shen, and J.L. Yi Inhibitory effects of blockage of intermediate conductance Ca(2 +)-activated K (+) channels on proliferation of hepatocellular carcinoma cells J. Huazhong Univ. Sci. Technol. Med. Sci. 33 2013 86 89
37. H. Jager, T. Dreker, A. Buck, K. Giehl, T. Gress, and S. Grissmer Blockage of intermediate-conductance Ca2 +-activated K + channels inhibit human pancreatic cancer cell growth in vitro Mol. Pharmacol. 65 2004 630 638
38. S. Amigorena, D. Choquet, J.L. Teillaud, H. Korn, and W.H. Fridman Ion channel blockers inhibit B cell activation at a precise stage of the G1 phase of the cell cycle. Possible involvement of K + channels J. Immunol. 144 1990 2038 2045
39. M.L. Day, S.J. Pickering, M.H. Johnson, and D.I. Cook Cell-cycle control of a large-conductance K + channel in mouse early embryos Nature 365 1993 560 562
40. S.A. Kotecha, and L.C. Schlichter A Kv1.5 to Kv1.3 switch in endogenous hippocampal microglia and a role in proliferation J. Neurosci. 19 1999 10680 10693
41. R. Chittajallu, Y. Chen, H. Wang, X. Yuan, C.A. Ghiani, T. Heckman, C.J. McBain, and V. Gallo Regulation of Kv1 subunit expression in oligodendrocyte progenitor cells and their role in G1/S phase progression of the cell cycle Proc. Natl. Acad. Sci. U. S. A. 99 2002 2350 2355
42. R. Vicente, A. Escalada, M. Coma, G. Fuster, E. Sanchez-Tillo, C. Lopez-Iglesias, C. Soler, C. Solsona, A. Celada, and A. Felipe Differential voltage-dependent K + channel responses during proliferation and activation in macrophages J. Biol. Chem. 278 2003 46307 46320
43. N. Villalonga, R. Martinez-Marmol, M. Roura-Ferrer, M. David, C. Valenzuela, C. Soler, and A. Felipe Cell cycle-dependent expression of Kv1.5 is involved in myoblast proliferation Biochim. Biophys. Acta 1783 2008 728 736
44. B. Nilius, and W. Wohlrab Potassium channels and regulation of proliferation of human melanoma cells J. Physiol. 445 1992 537 548
45. J.S. Strobl, W.F. Wonderlin, and D.C. Flynn Mitogenic signal transduction in human breast cancer cells Gen. Pharmacol. 26 1995 1643 1649
46. V. Rybalchenko, N. Prevarskaya, F. Van Coppenolle, G. Legrand, L. Lemonnier, X. Le Bourhis, and R. Skryma Verapamil inhibits proliferation of LNCaP human prostate cancer cells influencing K + channel gating Mol. Pharmacol. 59 2001 1376 1387
47. M. Abdul, A. Santo, and N. Hoosein Activity of potassium channel-blockers in breast cancer Anticancer Res. 23 2003 3347 3351
48. Q. Zhou, H.Y. Kwan, H.C. Chan, J.L. Jiang, S.C. Tam, and X. Yao Blockage of voltage-gated K + channels inhibits adhesion and proliferation of hepatocarcinoma cells Int. J. Mol. Med. 11 2003 261 266
49. T. Utermark, A. Alekov, H. Lerche, V. Abramowski, M. Giovannini, and C.O. Hanemann Quinidine impairs proliferation of neurofibromatosis type 2-deficient human malignant mesothelioma cells Cancer 97 2003 1955 1962
50. K. Preussat, C. Beetz, M. Schrey, R. Kraft, S. Wolfl, R. Kalff, and S. Patt Expression of voltage-gated potassium channels Kv1.3 and Kv1.5 in human gliomas Neurosci. Lett. 346 2003 33 36
51. H. Wulff, H.G. Knaus, M. Pennington, and K.G. Chandy K + channel expression during B cell differentiation: implications for immunomodulation and autoimmunity J. Immunol. 173 2004 776 786
52. W. Stuhmer, J.P. Ruppersberg, K.H. Schroter, B. Sakmann, M. Stocker, K.P. Giese, A. Perschke, A. Baumann, and O. Pongs Molecular basis of functional diversity of voltage-gated potassium channels in mammalian brain EMBO J. 8 1989 3235 3244
53. M. Grunnet, H.B. Rasmussen, A. Hay-Schmidt, and D.A. Klaerke The voltage-gated potassium channel subunit, Kv1.3, is expressed in epithelia Biochim. Biophys. Acta 1616 2003 85 94
54. R. Swanson, J. Marshall, J.S. Smith, J.B. Williams, M.B. Boyle, K. Folander, C.J. Luneau, J. Antanavage, C. Oliva, S.A. Buhrow, and et al. Cloning and expression of cDNA and genomic clones encoding three delayed rectifier potassium channels in rat brain Neuron 4 1990 929 939
55. J. Bielanska, J. Hernandez-Losa, T. Moline, R. Somoza, S. Ramon y Cajal, E. Condom, J.C. Ferreres, and A. Felipe Differential expression of Kv1.3 and Kv1.5 voltage-dependent K + channels in human skeletal muscle sarcomas Cancer Investig. 30 2012 203 208
56. Z. Varga, P. Hajdu, and G. Panyi Ion channels in T lymphocytes: an update on facts, mechanisms and therapeutic targeting in autoimmune diseases Immunol. Lett. 130 2010 19 25
57. G. Panyi, G. Vamosi, Z. Bacso, M. Bagdany, A. Bodnar, Z. Varga, R. Gaspar, L. Matyus, and S. Damjanovich Kv1.3 potassium channels are localized in the immunological synapse formed between cytotoxic and target cells Proc. Natl. Acad. Sci. U. S. A. 101 2004 1285 1290
58. H. Wulff, C. Beeton, and K.G. Chandy Potassium channels as therapeutic targets for autoimmune disorders Curr. Opin. Drug Discov. Dev. 6 2003 640 647
59. C. Beeton, M.W. Pennington, H. Wulff, S. Singh, D. Nugent, G. Crossley, I. Khaytin, P.A. Calabresi, C.Y. Chen, G.A. Gutman, and K.G. Chandy Targeting effector memory T cells with a selective peptide inhibitor of Kv1.3 channels for therapy of autoimmune diseases Mol. Pharmacol. 67 2005 1369 1381
60. I. Szabo, J. Bock, A. Jekle, M. Soddemann, C. Adams, F. Lang, M. Zoratti, and E. Gulbins A novel potassium channel in lymphocyte mitochondria J. Biol. Chem. 280 2005 12790 12798
61. I. Szabo, J. Bock, H. Grassme, M. Soddemann, B. Wilker, F. Lang, M. Zoratti, and E. Gulbins Mitochondrial potassium channel Kv1.3 mediates Bax-induced apoptosis in lymphocytes Proc. Natl. Acad. Sci. U. S. A. 105 2008 14861 14866
62. J. Xu, P. Wang, Y. Li, G. Li, L.K. Kaczmarek, Y. Wu, P.A. Koni, R.A. Flavell, and G.V. Desir The voltage-gated potassium channel Kv1.3 regulates peripheral insulin sensitivity Proc. Natl. Acad. Sci. U. S. A. 101 2004 3112 3117
63. J. Xu, P.A. Koni, P. Wang, G. Li, L. Kaczmarek, Y. Wu, Y. Li, R.A. Flavell, and G.V. Desir The voltage-gated potassium channel Kv1.3 regulates energy homeostasis and body weight Hum. Mol. Genet. 12 2003 551 559
64. J. Bielanska, J. Hernandez-Losa, M. Perez-Verdaguer, T. Moline, R. Somoza, Y.C.S. Ramon, E. Condom, J.C. Ferreres, and A. Felipe Voltage-dependent potassium channels Kv1.3 and Kv1.5 in human cancer Curr. Cancer Drug Targets 9 2009 904 914
65. A. Felipe, J. Bielanska, N. Comes, A. Vallejo, S. Roig, Y.C.S. Ramon, E. Condom, J. Hernandez-Losa, and J.C. Ferreres Targeting the voltage-dependent K(+) channels Kv1.3 and Kv1.5 as tumor biomarkers for cancer detection and prevention Curr. Med. Chem. 19 2012 661 674
66. N. Comes, J. Bielanska, A. Vallejo-Gracia, A. Serrano-Albarras, L. Marruecos, D. Gomez, C. Soler, E. Condom, Y.C.S. Ramon, J. Hernandez-Losa, J.C. Ferreres, and A. Felipe The voltage-dependent K channels Kv1.3 and Kv1.5 in human cancer Front. Physiol. 4 2013 283
67. M. Abdul, and N. Hoosein Reduced Kv1.3 potassium channel expression in human prostate cancer J. Membr. Biol. 214 2006 99 102
68. S.P. Fraser, J.A. Grimes, and M.B. Djamgoz Effects of voltage-gated ion channel modulators on rat prostatic cancer cell proliferation: comparison of strongly and weakly metastatic cell lines Prostate 44 2000 61 76
69. M.E. Laniado, S.P. Fraser, and M.B. Djamgoz Voltage-gated K(+) channel activity in human prostate cancer cell lines of markedly different metastatic potential: distinguishing characteristics of PC-3 and LNCaP cells Prostate 46 2001 262 274
70. M. Brevet, N. Haren, H. Sevestre, P. Merviel, and H. Ouadid-Ahidouch DNA methylation of K(v)1.3 potassium channel gene promoter is associated with poorly differentiated breast adenocarcinoma Cell. Physiol. Biochem. 24 2009 25 32
71. S.H. Jang, K.S. Kang, P.D. Ryu, and S.Y. Lee Kv1.3 voltage-gated K(+) channel subunit as a potential diagnostic marker and therapeutic target for breast cancer BMB Rep. 42 2009 535 539
72. J.J. Pancrazio, I.A. Tabbara, and Y.I. Kim Voltage-activated K + conductance and cell proliferation in small-cell lung cancer Anticancer Res. 13 1993 1231 1234
73. J. Bielanska, J. Hernandez-Losa, T. Moline, R. Somoza, S.R. Cajal, E. Condom, J.C. Ferreres, and A. Felipe Increased voltage-dependent K(+) channel Kv1.3 and Kv1.5 expression correlates with leiomyosarcoma aggressiveness Oncol. Lett. 4 2012 227 230
74. J.A. Grimes, S.P. Fraser, G.J. Stephens, J.E. Downing, M.E. Laniado, C.S. Foster, P.D. Abel, and M.B. Djamgoz Differential expression of voltage-activated Na + currents in two prostatic tumour cell lines: contribution to invasiveness in vitro FEBS Lett. 369 1995 290 294
75. M.E. Laniado, E.N. Lalani, S.P. Fraser, J.A. Grimes, G. Bhangal, M.B. Djamgoz, and P.D. Abel Expression and functional analysis of voltage-activated Na + channels in human prostate cancer cell lines and their contribution to invasion in vitro Am. J. Pathol. 150 1997 1213 1221
76. S.P. Fraser, J.A. Grimes, J.K. Diss, D. Stewart, J.O. Dolly, and M.B. Djamgoz Predominant expression of Kv1.3 voltage-gated K + channel subunit in rat prostate cancer cell lines: electrophysiological, pharmacological and molecular characterisation Pflugers Arch. 446 2003 559 571
77. M. Brevet, A. Ahidouch, H. Sevestre, P. Merviel, Y. El Hiani, M. Robbe, and H. Ouadid-Ahidouch Expression of K + channels in normal and cancerous human breast Histol. Histopathol. 23 2008 965 972
78. X. Wang, V. Tryndyak, E.O. Apostolov, X. Yin, S.V. Shah, I.P. Pogribny, and A.G. Basnakian Sensitivity of human prostate cancer cells to chemotherapeutic drugs depends on EndoG expression regulated by promoter methylation Cancer Lett. 270 2008 132 143
79. A. Vallejo-Gracia, J. Bielanska, J. Hernandez-Losa, J. Castellvi, M.C. Ruiz-Marcellan, S. Ramon y Cajal, E. Condom, J. Manils, C. Soler, N. Comes, J.C. Ferreres, and A. Felipe Emerging role for the voltage-dependent K + channel Kv1.5 in B-lymphocyte physiology: expression associated with human lymphoma malignancy J. Leukoc. Biol. 94 2013 779 789
80. I. Szabo, L. Leanza, E. Gulbins, and M. Zoratti Physiology of potassium channels in the inner membrane of mitochondria Pflugers Arch. 463 2012 231 246
81. I. Szabo, M. Zoratti, and E. Gulbins Contribution of voltage-gated potassium channels to the regulation of apoptosis FEBS Lett. 584 2010 2049 2056
82. R. Vicente, A. Escalada, N. Villalonga, L. Texido, M. Roura-Ferrer, M. Martin-Satue, C. Lopez-Iglesias, C. Soler, C. Solsona, M.M. Tamkun, and A. Felipe Association of Kv1.5 and Kv1.3 contributes to the major voltage-dependent K + channel in macrophages J. Biol. Chem. 281 2006 37675 37685
83. E. Gulbins, N. Sassi, H. Grassme, M. Zoratti, and I. Szabo Role of Kv1.3 mitochondrial potassium channel in apoptotic signalling in lymphocytes Biochim. Biophys. Acta 1797 2010 1251 1259
84. L. Leanza, L. Trentin, K.A. Becker, F. Frezzato, M. Zoratti, G. Semenzato, E. Gulbins, and I. Szabo Clofazimine, Psora-4 and PAP-1, inhibitors of the potassium channel Kv1.3, as a new and selective therapeutic strategy in chronic lymphocytic leukemia Leukemia 27 2013 1782 1785
85. L. Leanza, M. Zoratti, E. Gulbins, and I. Szabo Induction of apoptosis in macrophages via Kv1.3 and Kv1.5 potassium channels Curr. Med. Chem. 19 2012 5394 5404
86. Y. Cheng, E. Gulbins, and D. Siemen Activation of the permeability transition pore by Bax via inhibition of the mitochondrial BK channel Cell. Physiol. Biochem. 27 2011 191 200
87. Z. Rusznak, G. Bakondi, L. Kosztka, K. Pocsai, B. Dienes, J. Fodor, A. Telek, M. Gonczi, G. Szucs, and L. Csernoch Mitochondrial expression of the two-pore domain TASK-3 channels in malignantly transformed and non-malignant human cells Virchows Arch. 452 2008 415 426
88. A. Arcangeli, O. Crociani, E. Lastraioli, A. Masi, S. Pillozzi, and A. Becchetti Targeting ion channels in cancer: a novel frontier in antineoplastic therapy Curr. Med. Chem. 16 2009 66 93
89. S. Grissmer, A.N. Nguyen, J. Aiyar, D.C. Hanson, R.J. Mather, G.A. Gutman, M.J. Karmilowicz, D.D. Auperin, and K.G. Chandy Pharmacological characterization of five cloned voltage-gated K + channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines Mol. Pharmacol. 45 1994 1227 1234
90. J. Vennekamp, H. Wulff, C. Beeton, P.A. Calabresi, S. Grissmer, W. Hansel, and K.G. Chandy Kv1.3-blocking 5-phenylalkoxypsoralens: a new class of immunomodulators Mol. Pharmacol. 65 2004 1364 1374
91. R.J. Leonard, M.L. Garcia, R.S. Slaughter, and J.P. Reuben Selective blockers of voltage-gated K + channels depolarize human T lymphocytes: mechanism of the antiproliferative effect of charybdotoxin Proc. Natl. Acad. Sci. U. S. A. 89 1992 10094 10098
92. M. Garcia-Calvo, R.J. Leonard, J. Novick, S.P. Stevens, W. Schmalhofer, G.J. Kaczorowski, and M.L. Garcia Purification, characterization, and biosynthesis of margatoxin, a component of Centruroides margaritatus venom that selectively inhibits voltage-dependent potassium channels J. Biol. Chem. 268 1993 18866 18874
93. M.D. Cahalan, and K.G. Chandy Ion channels in the immune system as targets for immunosuppression Curr. Opin. Biotechnol. 8 1997 749 756
94. K.M. Mullen, M. Rozycka, H. Rus, L. Hu, C. Cudrici, E. Zafranskaia, M.W. Pennington, D.C. Johns, S.I. Judge, and P.A. Calabresi Potassium channels Kv1.3 and Kv1.5 are expressed on blood-derived dendritic cells in the central nervous system Ann. Neurol. 60 2006 118 127
95. M.M. Tamkun, K.M. Knoth, J.A. Walbridge, H. Kroemer, D.M. Roden, and D.M. Glover Molecular cloning and characterization of two voltage-gated K + channel cDNAs from human ventricle FASEB J. 5 1991 331 337
96. J. Bielanska, J. Hernandez-Losa, T. Moline, R. Somoza, Y.C.S. Ramon, E. Condom, J.C. Ferreres, and A. Felipe Voltage-dependent potassium channels Kv1.3 and Kv1.5 in human fetus Cell. Physiol. Biochem. 26 2010 219 226
97. T.M. Olson, A.E. Alekseev, X.K. Liu, S. Park, L.V. Zingman, M. Bienengraeber, S. Sattiraju, J.D. Ballew, A. Jahangir, and A. Terzic Kv1.5 channelopathy due to KCNA5 loss-of-function mutation causes human atrial fibrillation Hum. Mol. Genet. 15 2006 2185 2191
98. N.H. Nielsen, B.G. Winkel, J.K. Kanters, N. Schmitt, J. Hofman-Bang, H.S. Jensen, B.H. Bentzen, B. Sigurd, L.A. Larsen, P.S. Andersen, S. Haunso, K. Kjeldsen, M. Grunnet, M. Christiansen, and S.P. Olesen Mutations in the Kv1.5 channel gene KCNA5 in cardiac arrest patients Biochem. Biophys. Res. Commun. 354 2007 776 782
99. B. Attali, N. Wang, A. Kolot, A. Sobko, V. Cherepanov, and B. Soliven Characterization of delayed rectifier Kv channels in oligodendrocytes and progenitor cells J. Neurosci. 17 1997 8234 8245
100. N. Villalonga, M. David, J. Bielanska, T. Gonzalez, D. Parra, C. Soler, N. Comes, C. Valenzuela, and A. Felipe Immunomodulatory effects of diclofenac in leukocytes through the targeting of Kv1.3 voltage-dependent potassium channels Biochem. Pharmacol. 80 2010 858 866
101. N. Villalonga, M. David, J. Bielanska, R. Vicente, N. Comes, C. Valenzuela, and A. Felipe Immunomodulation of voltage-dependent K + channels in macrophages: molecular and biophysical consequences J. Gen. Physiol. 135 2010 135 147
102. S.N. MacFarlane, and H. Sontheimer Modulation of Kv1.5 currents by Src tyrosine phosphorylation: potential role in the differentiation of astrocytes J. Neurosci. 20 2000 5245 5253
103. N. Villalonga, A. Escalada, R. Vicente, E. Sanchez-Tillo, A. Celada, C. Solsona, and A. Felipe Kv1.3/Kv1.5 heteromeric channels compromise pharmacological responses in macrophages Biochem. Biophys. Res. Commun. 352 2007 913 918
104. S. Arvind, A. Arivazhagan, V. Santosh, and B.A. Chandramouli Differential expression of a novel voltage gated potassium channel-Kv 1.5 in astrocytomas and its impact on prognosis in glioblastoma Br. J. Neurosurg. 26 2012 16 20
105. J.W. Warmke, and B. Ganetzky A family of potassium channel genes related to eag in Drosophila and mammals Proc. Natl. Acad. Sci. U. S. A. 91 1994 3438 3442
106. C.K. Bauer, and J.R. Schwarz Physiology of EAG K + channels J. Membr. Biol. 182 2001 1 15
107. J. Ludwig, R. Weseloh, C. Karschin, Q. Liu, R. Netzer, B. Engeland, C. Stansfeld, and O. Pongs Cloning and functional expression of rat eag2, a new member of the ether-A-go-go family of potassium channels and comparison of its distribution with that of eag1 Mol. Cell. Neurosci. 16 2000 59 70
108. M. Ju, and D. Wray Molecular identification and characterisation of the human eag2 potassium channel FEBS Lett. 524 2002 204 210
109. R. Schonherr, G. Gessner, K. Lober, and S.H. Heinemann Functional distinction of human EAG1 and EAG2 potassium channels FEBS Lett. 514 2002 204 208
110. L.A. Pardo, and W. Stuhmer Eag1 as a cancer target Expert Opin. Ther. Targets 12 2008 837 843
111. T. Occhiodoro, L. Bernheim, J.H. Liu, P. Bijlenga, M. Sinnreich, C.R. Bader, and J. Fischer-Lougheed Cloning of a human ether-A-go-go potassium channel expressed in myoblasts at the onset of fusion FEBS Lett. 434 1998 177 182
112. A. Bruggemann, W. Stuhmer, and L.A. Pardo Mitosis-promoting factor-mediated suppression of a cloned delayed rectifier potassium channel expressed in Xenopus oocytes Proc. Natl. Acad. Sci. U. S. A. 94 1997 537 542
113. L.A. Pardo, A. Bruggemann, J. Camacho, and W. Stuhmer Cell cycle-related changes in the conducting properties of r-eag K + channels J. Cell Biol. 143 1998 767 775
114. J. Camacho, A. Sanchez, W. Stuhmer, and L.A. Pardo Cytoskeletal interactions determine the electrophysiological properties of human EAG potassium channels Pflugers Arch. 441 2000 167 174
115. A. Arcangeli, L. Bianchi, A. Becchetti, L. Faravelli, M. Coronnello, E. Mini, M. Olivotto, and E. Wanke A novel inward-rectifying K + current with a cell-cycle dependence governs the resting potential of mammalian neuroblastoma cells J. Physiol. 489 Pt 2 1995 455 471
116. A.S. Borowiec, F. Hague, N. Harir, S. Guenin, F. Guerineau, F. Gouilleux, M. Roudbaraki, K. Lassoued, and H. Ouadid-Ahidouch IGF-1 activates hEAG K(+) channels through an Akt-dependent signaling pathway in breast cancer cells: role in cell proliferation J. Cell. Physiol. 212 2007 690 701
117. H. Ouadid-Ahidouch, and A. Ahidouch K + channel expression in human breast cancer cells: involvement in cell cycle regulation and carcinogenesis J. Membr. Biol. 221 2008 1 6
118. B.R. Downie, A. Sanchez, H. Knotgen, C. Contreras-Jurado, M. Gymnopoulos, C. Weber, W. Stuhmer, and L.A. Pardo Eag1 expression interferes with hypoxia homeostasis and induces angiogenesis in tumors J. Biol. Chem. 283 2008 36234 36240
119. J.R. Agarwal, F. Griesinger, W. Stuhmer, and L.A. Pardo The potassium channel Ether a go-go is a novel prognostic factor with functional relevance in acute myeloid leukemia Mol. Cancer 9 2010 18
120. D. Gomez-Varela, E. Zwick-Wallasch, H. Knotgen, A. Sanchez, T. Hettmann, D. Ossipov, R. Weseloh, C. Contreras-Jurado, M. Rothe, W. Stuhmer, and L.A. Pardo Monoclonal antibody blockade of the human Eag1 potassium channel function exerts antitumor activity Cancer Res. 67 2007 7343 7349
121. C. Weber, F. Mello de Queiroz, B.R. Downie, A. Suckow, W. Stuhmer, and L.A. Pardo Silencing the activity and proliferative properties of the human EagI Potassium Channel by RNA Interference J. Biol. Chem. 281 2006 13030 13037
122. L.C. Cunha, E. Del Bel, L. Pardo, W. Stuhmer, and D.E.A.R. Titze RNA interference with EAG1 enhances interferon gamma injury to glioma cells in vitro Anticancer Res. 33 2013 865 870
123. B. Hemmerlein, R.M. Weseloh, F. Mello de Queiroz, H. Knotgen, A. Sanchez, M.E. Rubio, S. Martin, T. Schliephacke, M. Jenke, R. Heinz Joachim, W. Stuhmer, and L.A. Pardo Overexpression of Eag1 potassium channels in clinical tumours Mol. Cancer 5 2006 41
124. R.E. Garcia-Ferreiro, D. Kerschensteiner, F. Major, F. Monje, W. Stuhmer, and L.A. Pardo Mechanism of block of hEag1 K + channels by imipramine and astemizole J. Gen. Physiol. 124 2004 301 317
125. Y.E. Alfaro-Mora Human Eag1 potassium channel expression in lung cancer biopsies P.P. AACR, Proceedings of AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics Mol Cancer Ther vol. 10 2011 A nr C13 (San Francisco, CA)
126. H. Wulff, N.A. Castle, and L.A. Pardo Voltage-gated potassium channels as therapeutic targets Nat. Rev. Drug Discov. 8 2009 982 1001
127. D. Thomas, B. Gut, S. Karsai, A.B. Wimmer, K. Wu, G. Wendt-Nordahl, W. Zhang, S. Kathofer, W. Schoels, H.A. Katus, J. Kiehn, and C.A. Karle Inhibition of cloned HERG potassium channels by the antiestrogen tamoxifen Naunyn Schmiedebergs Arch. Pharmacol. 368 2003 41 48
128. D. Thomas, A.B. Wimmer, K. Wu, B.C. Hammerling, E.K. Ficker, Y.A. Kuryshev, J. Kiehn, H.A. Katus, W. Schoels, and C.A. Karle Inhibition of human ether-A-go-go-related gene potassium channels by alpha 1-adrenoceptor antagonists prazosin, doxazosin, and terazosin Naunyn Schmiedebergs Arch. Pharmacol. 369 2004 462 472
129. D. Urrego, A.P. Tomczak, F. Zahed, W. Stuhmer, and L.A. Pardo Potassium channels in cell cycle and cell proliferation Philos. Trans. R. Soc. Lond. B Biol. Sci. 369 2014 20130094
130. P. Bijlenga, T. Occhiodoro, J.H. Liu, C.R. Bader, L. Bernheim, and J. Fischer-Lougheed An ether-A-go-go K + current, Ih-eag, contributes to the hyperpolarization of human fusion-competent myoblasts J. Physiol. 512 Pt 2 1998 317 323
131. S. Martin, C. Lino de Oliveira, F. Mello de Queiroz, L.A. Pardo, W. Stuhmer, and E. Del Bel Eag1 potassium channel immunohistochemistry in the CNS of adult rat and selected regions of human brain Neuroscience 155 2008 833 844
132. R. Meyer, R. Schonherr, O. Gavrilova-Ruch, W. Wohlrab, and S.H. Heinemann Identification of ether a go-go and calcium-activated potassium channels in human melanoma cells J. Membr. Biol. 171 1999 107 115
133. O. Gavrilova-Ruch, K. Schonherr, G. Gessner, R. Schonherr, T. Klapperstuck, W. Wohlrab, and S.H. Heinemann Effects of imipramine on ion channels and proliferation of IGR1 melanoma cells J. Membr. Biol. 188 2002 137 149
134. H. Ouadid-Ahidouch, X. Le Bourhis, M. Roudbaraki, R.A. Toillon, P. Delcourt, and N. Prevarskaya Changes in the K + current-density of MCF-7 cells during progression through the cell cycle: possible involvement of a h-ether a-gogo K + channel Receptors Channels 7 2001 345 356
135. J. Ousingsawat, M. Spitzner, S. Puntheeranurak, L. Terracciano, L. Tornillo, L. Bubendorf, K. Kunzelmann, and R. Schreiber Expression of voltage-gated potassium channels in human and mouse colonic carcinoma Clin. Cancer Res. 13 2007 824 831
136. X.W. Ding, H.S. Luo, X. Jin, J.J. Yan, and Y.W. Ai Aberrant expression of Eag1 potassium channels in gastric cancer patients and cell lines Med. Oncol. 24 2007 345 350
137. O. Crociani, L. Guasti, M. Balzi, A. Becchetti, E. Wanke, M. Olivotto, R.S. Wymore, and A. Arcangeli Cell cycle-dependent expression of HERG1 and HERG1B isoforms in tumor cells J. Biol. Chem. 278 2003 2947 2955
138. X.W. Ding, X.G. Wang, H.S. Luo, S.Y. Tan, S. Gao, B. Luo, and H. Jiang Expression and prognostic roles of Eag1 in resected esophageal squamous cell carcinomas Dig. Dis. Sci. 53 2008 2039 2044
139. X. Wu, D. Zhong, B. Lin, W. Zhai, Z. Ding, and J. Wu p38 MAPK regulates the expression of ether a go-go potassium channel in human osteosarcoma cells Radiol. Oncol. 47 2013 42 49
140. M.G. del Pliego, E. Aguirre-Benitez, K. Paisano-Ceron, I. Valdovinos-Ramirez, C. Rangel-Morales, V. Rodriguez-Mata, C. Solano-Agama, D. Martin-Tapia, M.T. de la Vega, M. Saldoval-Balanzario, J. Camacho, and M.E. Mendoza-Garrido Expression of Eag1 K + channel and ErbBs in human pituitary adenomas: cytoskeleton arrangement patterns in cultured cells Int. J. Clin. Exp. Pathol. 6 2013 458 468
141. S.T. Menendez, M.A. Villaronga, J.P. Rodrigo, S. Alvarez-Teijeiro, D. Garcia-Carracedo, R.G. Urdinguio, M.F. Fraga, L.A. Pardo, C.G. Viloria, C. Suarez, and J.M. Garcia-Pedrero Frequent aberrant expression of the human ether a go-go (hEAG1) potassium channel in head and neck cancer: pathobiological mechanisms and clinical implications J. Mol. Med. (Berl.) 90 2012 1173 1184
142. V. Asher, A. Warren, R. Shaw, H. Sowter, A. Bali, and R. Khan The role of Eag and HERG channels in cell proliferation and apoptotic cell death in SK-OV-3 ovarian cancer cell line Cancer Cell Int. 11 2011 6
143. S. Patt, K. Preussat, C. Beetz, R. Kraft, M. Schrey, R. Kalff, K. Schonherr, and S.H. Heinemann Expression of ether a go-go potassium channels in human gliomas Neurosci. Lett. 368 2004 249 253
144. F. Mello de Queiroz, G. Suarez-Kurtz, W. Stuhmer, and L.A. Pardo Ether a go-go potassium channel expression in soft tissue sarcoma patients Mol. Cancer 5 2006 42
145. X.W. Ding, J.J. Yan, P. An, P. Lu, and H.S. Luo Aberrant expression of ether a go-go potassium channel in colorectal cancer patients and cell lines World J. Gastroenterol. 13 2007 1257 1261
146. G.A. Smith, H.W. Tsui, E.W. Newell, X. Jiang, X.P. Zhu, F.W. Tsui, and L.C. Schlichter Functional up-regulation of HERG K + channels in neoplastic hematopoietic cells J. Biol. Chem. 277 2002 18528 18534
147. M. Spitzner, J. Ousingsawat, K. Scheidt, K. Kunzelmann, and R. Schreiber Voltage-gated K + channels support proliferation of colonic carcinoma cells FASEB J. 21 2007 35 44
148. L. Diaz, I. Ceja-Ochoa, I. Restrepo-Angulo, F. Larrea, E. Avila-Chavez, R. Garcia-Becerra, E. Borja-Cacho, D. Barrera, E. Ahumada, P. Gariglio, E. Alvarez-Rios, R. Ocadiz-Delgado, E. Garcia-Villa, E. Hernandez-Gallegos, I. Camacho-Arroyo, A. Morales, D. Ordaz-Rosado, E. Garcia-Latorre, J. Escamilla, L.C. Sanchez-Pena, M. Saqui-Salces, A. Gamboa-Dominguez, E. Vera, M. Uribe-Ramirez, J. Murbartian, C.S. Ortiz, C. Rivera-Guevara, A. De Vizcaya-Ruiz, and J. Camacho Estrogens and human papilloma virus oncogenes regulate human ether-A-go-go-1 potassium channel expression Cancer Res. 69 2009 3300 3307
149. A.K. Adams, T.M. Wise-Draper, and S.I. Wells Human papillomavirus induced transformation in cervical and head and neck cancers Cancers (Basel) 6 2014 1793 1820
150. L. Lorenzon, M. Ferri, E. Pilozzi, M.R. Torrisi, V. Ziparo, and D. French Human papillomavirus and colorectal cancer: evidences and pitfalls of published literature Int. J. Colorectal Dis. 26 2011 135 142
151. A.R. Garbuglia Human papillomavirus in head and neck cancer Cancers (Basel) 6 2014 1705 1726
152. Y. Tolstov, B. Hadaschik, S. Pahernik, M. Hohenfellner, and S. Duensing Human papillomaviruses in urological malignancies: a critical assessment Urol. Oncol. 32 2014 46 e19-27
153. A. Masi, A. Becchetti, R. Restano-Cassulini, S. Polvani, G. Hofmann, A.M. Buccoliero, M. Paglierani, B. Pollo, G.L. Taddei, P. Gallina, N. Di Lorenzo, S. Franceschetti, E. Wanke, and A. Arcangeli hERG1 channels are overexpressed in glioblastoma multiforme and modulate VEGF secretion in glioblastoma cell lines Br. J. Cancer 93 2005 781 792
154. Y. Chen, A. Sanchez, M.E. Rubio, T. Kohl, L.A. Pardo, and W. Stuhmer Functional K(v)10.1 channels localize to the inner nuclear membrane PLoS ONE 6 2011 e19257
155. Z. Pezer, and D. Ugarkovic Role of non-coding RNA and heterochromatin in aneuploidy and cancer Semin. Cancer Biol. 18 2008 123 130
156. C. Toral, M.E. Mendoza-Garrido, E. Azorin, E. Hernandez-Gallegos, J.C. Gomora, D.M. Delgadillo, C. Solano-Agama, and J. Camacho Effect of extracellular matrix on adhesion, viability, actin cytoskeleton and K + currents of cells expressing human ether a go-go channels Life Sci. 81 2007 255 265
157. M. Spitzner, J.R. Martins, R.B. Soria, J. Ousingsawat, K. Scheidt, R. Schreiber, and K. Kunzelmann Eag1 and Bestrophin 1 are up-regulated in fast-growing colonic cancer cells J. Biol. Chem. 283 2008 7421 7428
158. A.P. Hegle, D.D. Marble, and G.F. Wilson A voltage-driven switch for ion-independent signaling by ether-A-go-go K + channels Proc. Natl. Acad. Sci. U. S. A. 103 2006 2886 2891
159. V. Asher, H. Sowter, R. Shaw, A. Bali, and R. Khan Eag and HERG potassium channels as novel therapeutic targets in cancer World J. Surg. Oncol. 8 2010 113
160. F. Hartung, W. Stuhmer, and L.A. Pardo Tumor cell-selective apoptosis induction through targeting of K(V)10.1 via bifunctional TRAIL antibody Mol. Cancer 10 2011 109
161. M.C. Sanguinetti, C. Jiang, M.E. Curran, and M.T. Keating A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel Cell 81 1995 299 307
162. R. Schonherr, B. Rosati, S. Hehl, V.G. Rao, A. Arcangeli, M. Olivotto, S.H. Heinemann, and E. Wanke Functional role of the slow activation property of ERG K + channels Eur. J. Neurosci. 11 1999 753 760
163. T.V. McDonald, Z. Yu, Z. Ming, E. Palma, M.B. Meyers, K.W. Wang, S.A. Goldstein, and G.I. Fishman A minK-HERG complex regulates the cardiac potassium current I(Kr) Nature 388 1997 289 292
164. A.L. Pond, B.K. Scheve, A.T. Benedict, K. Petrecca, D.R. Van Wagoner, A. Shrier, and J.M. Nerbonne Expression of distinct ERG proteins in rat, mouse, and human heart. Relation to functional I(Kr) channels J. Biol. Chem. 275 2000 5997 6006
165. A. Cherubini, G.L. Taddei, O. Crociani, M. Paglierani, A.M. Buccoliero, L. Fontana, I. Noci, P. Borri, E. Borrani, M. Giachi, A. Becchetti, B. Rosati, E. Wanke, M. Olivotto, and A. Arcangeli HERG potassium channels are more frequently expressed in human endometrial cancer as compared to non-cancerous endometrium Br. J. Cancer 83 2000 1722 1729
166. S. Pillozzi, M.F. Brizzi, M. Balzi, O. Crociani, A. Cherubini, L. Guasti, B. Bartolozzi, A. Becchetti, E. Wanke, P.A. Bernabei, M. Olivotto, L. Pegoraro, and A. Arcangeli HERG potassium channels are constitutively expressed in primary human acute myeloid leukemias and regulate cell proliferation of normal and leukemic hemopoietic progenitors Leukemia 16 2002 1791 1798
167. E. Lastraioli, L. Guasti, O. Crociani, S. Polvani, G. Hofmann, H. Witchel, L. Bencini, M. Calistri, L. Messerini, M. Scatizzi, R. Moretti, E. Wanke, M. Olivotto, G. Mugnai, and A. Arcangeli herg1 gene and HERG1 protein are overexpressed in colorectal cancers and regulate cell invasion of tumor cells Cancer Res. 64 2004 606 611
168. A. Arcangeli Expression and role of hERG channels in cancer cells Novartis Found. Symp. 266 2005 225 232 (discussion 232-224)
169. X.W. Ding, W.B. Yang, S. Gao, W. Wang, Z. Li, W.M. Hu, J.J. Li, and H.S. Luo Prognostic significance of hERG1 expression in gastric cancer Dig. Dis. Sci. 55 2010 1004 1010
170. X.D. Shao, K.C. Wu, X.Z. Guo, M.J. Xie, J. Zhang, and D.M. Fan Expression and significance of HERG protein in gastric cancer Cancer Biol. Ther. 7 2008 45 50
171. L.A. Pardo, and W. Stuhmer Eag1: an emerging oncological target Cancer Res. 68 2008 1611 1613
172. H. Ouadid-Ahidouch, F. Chaussade, M. Roudbaraki, C. Slomianny, E. Dewailly, P. Delcourt, and N. Prevarskaya KV1.1 K(+) channels identification in human breast carcinoma cells: involvement in cell proliferation Biochem. Biophys. Res. Commun. 278 2000 272 277
173. X.D. Shao, K.C. Wu, Z.M. Hao, L. Hong, J. Zhang, and D.M. Fan The potent inhibitory effects of cisapride, a specific blocker for human ether-A-go-go-related gene (HERG) channel, on gastric cancer cells Cancer Biol. Ther. 4 2005 295 301
174. J. Zhao, X.L. Wei, Y.S. Jia, and J.Q. Zheng Silencing of herg gene by shRNA inhibits SH-SY5Y cell growth in vitro and in vivo Eur. J. Pharmacol. 579 2008 50 57
175. G. Glassmeier, K. Hempel, I. Wulfsen, C.K. Bauer, U. Schumacher, and J.R. Schwarz Inhibition of HERG1 K + channel protein expression decreases cell proliferation of human small cell lung cancer cells Pflugers Arch. 463 2012 365 376
176. E. Afrasiabi, M. Hietamaki, T. Viitanen, P. Sukumaran, N. Bergelin, and K. Tornquist Expression and significance of HERG (KCNH2) potassium channels in the regulation of MDA-MB-435S melanoma cell proliferation and migration Cell. Signal. 22 2010 57 64
177. J.L. Overholt, E. Ficker, T. Yang, H. Shams, G.R. Bright, and N.R. Prabhakar HERG-Like potassium current regulates the resting membrane potential in glomus cells of the rabbit carotid body J. Neurophysiol. 83 2000 1150 1157
178. O. Crociani, F. Zanieri, S. Pillozzi, E. Lastraioli, M. Stefanini, A. Fiore, A. Fortunato, M. D'Amico, M. Masselli, E. De Lorenzo, L. Gasparoli, M. Chiu, O. Bussolati, A. Becchetti, and A. Arcangeli hERG1 channels modulate integrin signaling to trigger angiogenesis and tumor progression in colorectal cancer Sci. Rep. 3 2013 3308
179. A. Becchetti, and A. Arcangeli Integrins and ion channels in cell migration: implications for neuronal development, wound healing and metastatic spread Adv. Exp. Med. Biol. 674 2010 107 123
180. S. Pillozzi, M.F. Brizzi, P.A. Bernabei, B. Bartolozzi, R. Caporale, V. Basile, V. Boddi, L. Pegoraro, A. Becchetti, and A. Arcangeli VEGFR-1 (FLT-1), beta1 integrin, and hERG K + channel for a macromolecular signaling complex in acute myeloid leukemia: role in cell migration and clinical outcome Blood 110 2007 1238 1250
181. S. Pillozzi, M. Masselli, E. De Lorenzo, B. Accordi, E. Cilia, O. Crociani, A. Amedei, M. Veltroni, M. D'Amico, G. Basso, A. Becchetti, D. Campana, and A. Arcangeli Chemotherapy resistance in acute lymphoblastic leukemia requires hERG1 channels and is overcome by hERG1 blockers Blood 117 2011 902 914
182. G. Hofmann, P.A. Bernabei, O. Crociani, A. Cherubini, L. Guasti, S. Pillozzi, E. Lastraioli, S. Polvani, B. Bartolozzi, V. Solazzo, L. Gragnani, P. Defilippi, B. Rosati, E. Wanke, M. Olivotto, and A. Arcangeli HERG K + channels activation during beta(1) integrin-mediated adhesion to fibronectin induces an up-regulation of alpha(v)beta(3) integrin in the preosteoclastic leukemia cell line FLG 29.1 J. Biol. Chem. 276 2001 4923 4931
183. H. Li, Y.M. Du, L. Guo, S. Jie, S. Zhang, W. Du, X. Chen, W. Liu, L. Fan, J. Zhu, A. Zou, and S. Huang The role of hERG1 K + channels and a functional link between hERG1 K + channels and SDF-1 in acute leukemic cell migration Exp. Cell Res. 315 2009 2256 2264
184. M.Y. Asghar, T. Viitanen, K. Kemppainen, and K. Tornquist Sphingosine 1-phosphate and human ether-a'-go-go-related gene potassium channels modulate migration in human anaplastic thyroid cancer cells Endocr. Relat. Cancer 19 2012 667 680
185. A. Arcangeli, A. Becchetti, A. Mannini, G. Mugnai, P. De Filippi, G. Tarone, M.R. Del Bene, E. Barletta, E. Wanke, and M. Olivotto Integrin-mediated neurite outgrowth in neuroblastoma cells depends on the activation of potassium channels J. Cell Biol. 122 1993 1131 1143
186. N. Chiesa, B. Rosati, A. Arcangeli, M. Olivotto, and E. Wanke A novel role for HERG K + channels: spike-frequency adaptation J. Physiol. 501 Pt 2 1997 313 318
187. A. Cherubini, G. Hofmann, S. Pillozzi, L. Guasti, O. Crociani, E. Cilia, P. Di Stefano, S. Degani, M. Balzi, M. Olivotto, E. Wanke, A. Becchetti, P. Defilippi, R. Wymore, and A. Arcangeli Human ether-A-go-go-related gene 1 channels are physically linked to beta1 integrins and modulate adhesion-dependent signaling Mol. Biol. Cell 16 2005 2972 2983
188. A. Arcangeli, and A. Becchetti Complex functional interaction between integrin receptors and ion channels Trends Cell Biol. 16 2006 631 639
189. M.J. Saganich, E. Machado, and B. Rudy Differential expression of genes encoding subthreshold-operating voltage-gated K + channels in brain J. Neurosci. 21 2001 4609 4624
190. A. Arcangeli, A. Becchetti, A. Cherubini, O. Crociani, P. Defilippi, L. Guasti, G. Hofmann, S. Pillozzi, M. Olivotto, and E. Wanke Physical and functional interaction between integrins and hERG potassium channels Biochem. Soc. Trans. 32 2004 826 827
191. L. Bianchi, A. Arcangeli, P. Bartolini, G. Mugnai, E. Wanke, and M. Olivotto An inward rectifier K + current modulates in neuroblastoma cells the tyrosine phosphorylation of the pp125FAK and associated proteins: role in neuritogenesis Biochem. Biophys. Res. Commun. 210 1995 823 829
192. A. Arcangeli, S. Pillozzi, and A. Becchetti Targeting ion channels in leukemias: a new challenge for treatment Curr. Med. Chem. 19 2012 683 696
193. S. Pillozzi, and A. Arcangeli Physical and functional interaction between integrins and hERG1 channels in cancer cells Adv. Exp. Med. Biol. 674 2010 55 67
194. U. Banderali, D. Belke, A. Singh, A. Jayanthan, W.R. Giles, and A. Narendran Curcumin blocks Kv11.1 (erg) potassium current and slows proliferation in the infant acute monocytic leukemia cell line THP-1 Cell. Physiol. Biochem. 28 2011 1169 1180
195. E. Lastraioli, A. Taddei, L. Messerini, C.E. Comin, M. Festini, M. Giannelli, A. Tomezzoli, M. Paglierani, G. Mugnai, G. De Manzoni, P. Bechi, and A. Arcangeli hERG1 channels in human esophagus: evidence for their aberrant expression in the malignant progression of Barrett's esophagus J. Cell. Physiol. 209 2006 398 404
196. D. Hanahan, and R.A. Weinberg The hallmarks of cancer Cell 100 2000 57 70
197. A. Fiore, L. Carraresi, A. Morabito, S. Polvani, A. Fortunato, E. Lastraioli, A.P. Femia, E. De Lorenzo, G. Caderni, and A. Arcangeli Characterization of hERG1 channel role in mouse colorectal carcinogenesis Cancer Med. 2 2013 583 594
198. T. Suzuki, and K. Takimoto Selective expression of HERG and Kv2 channels influences proliferation of uterine cancer cells Int. J. Oncol. 25 2004 153 159
199. J. Roy, B. Vantol, E.A. Cowley, J. Blay, and P. Linsdell Pharmacological separation of hEAG and hERG K + channel function in the human mammary carcinoma cell line MCF-7 Oncol. Rep. 19 2008 1511 1516
200. A. Sette, J. Spadavecchia, J. Landoulsi, S. Casale, B. Haye, O. Crociani, and A. Arcangeli Development of novel anti-Kv 11.1 antibody-conjugated PEG-TiO nanoparticles for targeting pancreatic ductal adenocarcinoma cells J. Nanoparticle Res. 15 2013 2111
201. M. D'Amico, L. Gasparoli, and A. Arcangeli Potassium channels: novel emerging biomarkers and targets for therapy in cancer Recent Pat. Anticancer Drug Discov. 8 2013 53 65
202. J.S. Mitcheson hERG potassium channels and the structural basis of drug-induced arrhythmias Chem. Res. Toxicol. 21 2008 1005 1010
203. L. Guasti, O. Crociani, E. Redaelli, S. Pillozzi, S. Polvani, M. Masselli, T. Mello, A. Galli, A. Amedei, R.S. Wymore, E. Wanke, and A. Arcangeli Identification of a posttranslational mechanism for the regulation of hERG1 K + channel expression and hERG1 current density in tumor cells Mol. Cell. Biol. 28 2008 5043 5060
204. S.B. Ganapathi, M. Kester, and K.S. Elmslie State-dependent block of HERG potassium channels by R-roscovitine: implications for cancer therapy Am. J. Physiol. Cell Physiol. 296 2009 C701 C710
205. K.A. Ketchum, W.J. Joiner, A.J. Sellers, L.K. Kaczmarek, and S.A. Goldstein A new family of outwardly rectifying potassium channel proteins with two pore domains in tandem Nature 376 1995 690 695
206. S. Rajan, E. Wischmeyer, G. Xin Liu, R. Preisig-Muller, J. Daut, A. Karschin, and C. Derst TASK-3, a novel tandem pore domain acid-sensitive K + channel. An extracellular histiding as pH sensor J. Biol. Chem. 275 2000 16650 16657
207. S.A. Goldstein, D. Bockenhauer, I. O'Kelly, and N. Zilberberg Potassium leak channels and the KCNK family of two-P-domain subunits Nat. Rev. Neurosci. 2 2001 175 184
208. S.G. Meuth, M.I. Aller, T. Munsch, T. Schuhmacher, T. Seidenbecher, P. Meuth, C. Kleinschnitz, H.C. Pape, H. Wiendl, W. Wisden, and T. Budde The contribution of TWIK-related acid-sensitive K +-containing channels to the function of dorsal lateral geniculate thalamocortical relay neurons Mol. Pharmacol. 69 2006 1468 1476
209. S.G. Meuth, T. Budde, T. Kanyshkova, T. Broicher, T. Munsch, and H.C. Pape Contribution of TWIK-related acid-sensitive K + channel 1 (TASK1) and TASK3 channels to the control of activity modes in thalamocortical neurons J. Neurosci. 23 2003 6460 6469
210. P.M. Larkman, and E.M. Perkins A TASK-like pH- and amine-sensitive 'leak' K + conductance regulates neonatal rat facial motoneuron excitability in vitro Eur. J. Neurosci. 21 2005 679 691
211. A. Olschewski, Y. Li, B. Tang, J. Hanze, B. Eul, R.M. Bohle, J. Wilhelm, R.E. Morty, M.E. Brau, E.K. Weir, G. Kwapiszewska, W. Klepetko, W. Seeger, and H. Olschewski Impact of TASK-1 in human pulmonary artery smooth muscle cells Circ. Res. 98 2006 1072 1080
212. S.N. Skatchkov, M.J. Eaton, Y.M. Shuba, Y.V. Kucheryavykh, C. Derst, R.W. Veh, A. Wurm, I. Iandiev, T. Pannicke, A. Bringmann, and A. Reichenbach Tandem-pore domain potassium channels are functionally expressed in retinal (Muller) glial cells Glia 53 2006 266 276
213. E.M. Talley, Q. Lei, J.E. Sirois, and D.A. Bayliss TASK-1, a two-pore domain K + channel, is modulated by multiple neurotransmitters in motoneurons Neuron 25 2000 399 410
214. F. Duprat, F. Lesage, M. Fink, R. Reyes, C. Heurteaux, and M. Lazdunski TASK, a human background K + channel to sense external pH variations near physiological pH EMBO J. 16 1997 5464 5471
215. C.G. Chapman, H.J. Meadows, R.J. Godden, D.A. Campbell, M. Duckworth, R.E. Kelsell, P.R. Murdock, A.D. Randall, G.I. Rennie, and I.S. Gloger Cloning, localisation and functional expression of a novel human, cerebellum specific, two pore domain potassium channel Brain Res. Mol. Brain Res. 82 2000 74 83
216. Y. Kim, H. Bang, and D. Kim TASK-3, a new member of the tandem pore K(+) channel family J. Biol. Chem. 275 2000 9340 9347
217. K.J. Buckler, B.A. Williams, and E. Honore An oxygen-, acid- and anaesthetic-sensitive TASK-like background potassium channel in rat arterial chemoreceptor cells J. Physiol. 525 Pt 1 2000 135 142
218. T. Budde, P. Coulon, M. Pawlowski, P. Meuth, T. Kanyshkova, A. Japes, S.G. Meuth, and H.C. Pape Reciprocal modulation of I (h) and I (TASK) in thalamocortical relay neurons by halothane Pflugers Arch. 456 2008 1061 1073
219. H.J. Meadows, and A.D. Randall Functional characterisation of human TASK-3, an acid-sensitive two-pore domain potassium channel Neuropharmacology 40 2001 551 559
220. E.M. Talley, and D.A. Bayliss Modulation of TASK-1 (Kcnk3) and TASK-3 (Kcnk9) potassium channels: volatile anesthetics and neurotransmitters share a molecular site of action J. Biol. Chem. 277 2002 17733 17742
221. A.J. Patel, E. Honore, F. Lesage, M. Fink, G. Romey, and M. Lazdunski Inhalational anesthetics activate two-pore-domain background K + channels Nat. Neurosci. 2 1999 422 426
222. D.A. Bayliss, and P.Q. Barrett Emerging roles for two-pore-domain potassium channels and their potential therapeutic impact Trends Pharmacol. Sci. 29 2008 566 575
223. I. Kovacs, K. Pocsai, G. Czifra, L. Sarkadi, G. Szucs, Z. Nemes, and Z. Rusznak TASK-3 immunoreactivity shows differential distribution in the human gastrointestinal tract Virchows Arch. 446 2005 402 410
224. G. Czirjak, T. Fischer, A. Spat, F. Lesage, and P. Enyedi TASK (TWIK-related acid-sensitive K + channel) is expressed in glomerulosa cells of rat adrenal cortex and inhibited by angiotensin II Mol. Endocrinol. 14 2000 863 874
225. G. Czirjak, and P. Enyedi TASK-3 dominates the background potassium conductance in rat adrenal glomerulosa cells Mol. Endocrinol. 16 2002 621 629
226. A.D. O'Connell, M.J. Morton, and M. Hunter Two-pore domain K + channels-molecular sensors Biochim. Biophys. Acta 1566 2002 152 161
227. J. Chemin, C. Girard, F. Duprat, F. Lesage, G. Romey, and M. Lazdunski Mechanisms underlying excitatory effects of group I metabotropic glutamate receptors via inhibition of 2P domain K + channels EMBO J. 22 2003 5403 5411
228. M.I. Aller, E.L. Veale, A.M. Linden, C. Sandu, M. Schwaninger, L.J. Evans, E.R. Korpi, A. Mathie, W. Wisden, and S.G. Brickley Modifying the subunit composition of TASK channels alters the modulation of a leak conductance in cerebellar granule neurons J. Neurosci. 25 2005 11455 11467
229. J. Han, C. Gnatenco, C.D. Sladek, and D. Kim Background and tandem-pore potassium channels in magnocellular neurosecretory cells of the rat supraoptic nucleus J. Physiol. 546 2003 625 639
230. M.E. Hartness, A. Lewis, G.J. Searle, I. O'Kelly, C. Peers, and P.J. Kemp Combined antisense and pharmacological approaches implicate hTASK as an airway O(2) sensing K(+) channel J. Biol. Chem. 276 2001 26499 26508
231. C.P. Washburn, J.E. Sirois, E.M. Talley, P.G. Guyenet, and D.A. Bayliss Serotonergic raphe neurons express TASK channel transcripts and a TASK-like pH- and halothane-sensitive K + conductance J. Neurosci. 22 2002 1256 1265
232. K. Pocsai, L. Kosztka, G. Bakondi, M. Gonczi, J. Fodor, B. Dienes, P. Szentesi, I. Kovacs, R. Feniger-Barish, E. Kopf, D. Zharhary, G. Szucs, L. Csernoch, and Z. Rusznak Melanoma cells exhibit strong intracellular TASK-3-specific immunopositivity in both tissue sections and cell culture Cell. Mol. Life Sci. 63 2006 2364 2376
233. C.J. Kim, Y.G. Cho, S.W. Jeong, Y.S. Kim, S.Y. Kim, S.W. Nam, S.H. Lee, N.J. Yoo, J.Y. Lee, and W.S. Park Altered expression of KCNK9 in colorectal cancers APMIS 112 2004 588 594
234. L. Pei, O. Wiser, A. Slavin, D. Mu, S. Powers, L.Y. Jan, and T. Hoey Oncogenic potential of TASK3 (Kcnk9) depends on K + channel function Proc. Natl. Acad. Sci. U. S. A. 100 2003 7803 7807
235. S. Harguindey, G. Orive, J. Luis Pedraz, A. Paradiso, and S.J. Reshkin The role of pH dynamics and the Na +/H + antiporter in the etiopathogenesis and treatment of cancer. Two faces of the same coin-one single nature Biochim. Biophys. Acta 1756 2005 1 24
236. M. Hoglund, D. Gisselsson, G.B. Hansen, T. Sall, F. Mitelman, and M. Nilbert Dissecting karyotypic patterns in colorectal tumors: two distinct but overlapping pathways in the adenoma-carcinoma transition Cancer Res. 62 2002 5939 5946
237. I. Lauritzen, M. Zanzouri, E. Honore, F. Duprat, M.U. Ehrengruber, M. Lazdunski, and A.J. Patel K +-dependent cerebellar granule neuron apoptosis. Role of task leak K + channels J. Biol. Chem. 278 2003 32068 32076
238. C. Liu, J.F. Cotten, J.A. Schuyler, C.S. Fahlman, J.D. Au, P.E. Bickler, and C.S. Yost Protective effects of TASK-3 (KCNK9) and related 2P K channels during cellular stress Brain Res. 1031 2005 164 173
239. A. Innamaa, L. Jackson, V. Asher, G. Van Shalkwyk, A. Warren, D. Hay, A. Bali, H. Sowter, and R. Khan Expression and prognostic significance of the oncogenic K2P potassium channel KCNK9 (TASK-3) in ovarian carcinoma Anticancer Res. 33 2013 1401 1408
240. L. Kosztka, Z. Rusznak, D. Nagy, Z. Nagy, J. Fodor, G. Szucs, A. Telek, M. Gonczi, O. Ruzsnavszky, N. Szentandrassy, and L. Csernoch Inhibition of TASK-3 (KCNK9) channel biosynthesis changes cell morphology and decreases both DNA content and mitochondrial function of melanoma cells maintained in cell culture Melanoma Res. 21 2011 308 322
241. A. Szewczyk, W. Jarmuszkiewicz, and W.S. Kunz Mitochondrial potassium channels IUBMB Life 61 2009 134 143
242. G.W. Lee, H.S. Park, E.J. Kim, Y.W. Cho, G.T. Kim, Y.J. Mun, E.J. Choi, J.S. Lee, J. Han, and D. Kang Reduction of breast cancer cell migration via up-regulation of TASK-3 two-pore domain K + channel Acta Physiol. (Oxf.) 204 2012 513 524
243. E.K. Hoffmann, and C. Hougaard Intracellular signalling involved in activation of the volume-sensitive K + current in Ehrlich ascites tumour cells Comp. Biochem. Physiol. A Mol. Integr. Physiol. 130 2001 355 366
244. C.R. Ries, and E. Puil Ionic mechanism of isoflurane's actions on thalamocortical neurons J. Neurophysiol. 81 1999 1802 1809
245. B. Musset, S.G. Meuth, G.X. Liu, C. Derst, S. Wegner, H.C. Pape, T. Budde, R. Preisig-Muller, and J. Daut Effects of divalent cations and spermine on the K + channel TASK-3 and on the outward current in thalamic neurons J. Physiol. 572 2006 639 657
246. F. Maingret, A.J. Patel, M. Lazdunski, and E. Honore The endocannabinoid anandamide is a direct and selective blocker of the background K(+) channel TASK-1 EMBO J. 20 2001 47 54
247. M. Gomez-Angelats, C.D. Bortner, and J.A. Cidlowski Cell volume regulation in immune cell apoptosis Cell Tissue Res. 301 2000 33 42
248. S.P. Yu, L.M. Canzoniero, and D.W. Choi Ion homeostasis and apoptosis Curr. Opin. Cell Biol. 13 2001 405 411
249. S.P. Yu Regulation and critical role of potassium homeostasis in apoptosis Prog. Neurobiol. 70 2003 363 386
250. S.P. Yu, and D.W. Choi Ions, cell volume, and apoptosis Proc. Natl. Acad. Sci. U. S. A. 97 2000 9360 9362
251. Y. Okada, and E. Maeno Apoptosis, cell volume regulation and volume-regulatory chloride channels Comp. Biochem. Physiol. A Mol. Integr. Physiol. 130 2001 377 383
252. C.H. Kindler, C.S. Yost, and A.T. Gray Local anesthetic inhibition of baseline potassium channels with two pore domains in tandem Anesthesiology 90 1999 1092 1102
253. J.E. Sirois, Q. Lei, E.M. Talley, C. Lynch III, and D.A. Bayliss The TASK-1 two-pore domain K + channel is a molecular substrate for neuronal effects of inhalation anesthetics J. Neurosci. 20 2000 6347 6354
254. A.D. Medhurst, G. Rennie, C.G. Chapman, H. Meadows, M.D. Duckworth, R.E. Kelsell, I.I. Gloger, and M.N. Pangalos Distribution analysis of human two pore domain potassium channels in tissues of the central nervous system and periphery Brain Res. Mol. Brain Res. 86 2001 101 114
255. J. Han, J. Truell, C. Gnatenco, and D. Kim Characterization of four types of background potassium channels in rat cerebellar granule neurons J. Physiol. 542 2002 431 444
256. A. Barbuti, S. Ishii, T. Shimizu, R.B. Robinson, and S.J. Feinmark Block of the background K(+) channel TASK-1 contributes to arrhythmogenic effects of platelet-activating factor Am. J. Physiol. Heart Circ. Physiol. 282 2002 H2024 H2030
257. D. Leonoudakis, A.T. Gray, B.D. Winegar, C.H. Kindler, M. Harada, D.M. Taylor, R.A. Chavez, J.R. Forsayeth, and C.S. Yost An open rectifier potassium channel with two pore domains in tandem cloned from rat cerebellum J. Neurosci. 18 1998 868 877
258. G. Czirjak, and P. Enyedi Formation of functional heterodimers between the TASK-1 and TASK-3 two-pore domain potassium channel subunits J. Biol. Chem. 277 2002 5426 5432
259. D. Kim, E.J. Cavanaugh, I. Kim, and J.L. Carroll Heteromeric TASK-1/TASK-3 is the major oxygen-sensitive background K + channel in rat carotid body glomus cells J. Physiol. 587 2009 2963 2975
260. F. Lesage, and M. Lazdunski Molecular and functional properties of two-pore-domain potassium channels Am. J. Physiol. Ren. Physiol. 279 2000 F793 F801
261. D. Cavalieri, P. Dolara, E. Mini, C. Luceri, C. Castagnini, S. Toti, K. Maciag, C. De Filippo, S. Nobili, M. Morganti, C. Napoli, G. Tonini, M. Baccini, A. Biggeri, F. Tonelli, R. Valanzano, C. Orlando, S. Gelmini, F. Cianchi, L. Messerini, and L. Luzzatto Analysis of gene expression profiles reveals novel correlations with the clinical course of colorectal cancer Oncol. Res. 16 2007 535 548
262. I. Voloshyna, A. Besana, M. Castillo, T. Matos, I.B. Weinstein, M. Mansukhani, R.B. Robinson, C. Cordon-Cardo, and S.J. Feinmark TREK-1 is a novel molecular target in prostate cancer Cancer Res. 68 2008 1197 1203
263. K.H. Taylor, K.E. Pena-Hernandez, J.W. Davis, G.L. Arthur, D.J. Duff, H. Shi, F.B. Rahmatpanah, O. Sjahputera, and C.W. Caldwell Large-scale CpG methylation analysis identifies novel candidate genes and reveals methylation hotspots in acute lymphoblastic leukemia Cancer Res. 67 2007 2617 2625
264. E.M. Talley, G. Solorzano, Q. Lei, D. Kim, and D.A. Bayliss Cns distribution of members of the two-pore-domain (KCNK) potassium channel family J. Neurosci. 21 2001 7491 7505
265. A.J. Patel, E. Honore, F. Maingret, F. Lesage, M. Fink, F. Duprat, and M. Lazdunski A mammalian two pore domain mechano-gated S-like K + channel EMBO J. 17 1998 4283 4290
266. F. Maingret, I. Lauritzen, A.J. Patel, C. Heurteaux, R. Reyes, F. Lesage, M. Lazdunski, and E. Honore TREK-1 is a heat-activated background K(+) channel EMBO J. 19 2000 2483 2491
267. F. Maingret, A.J. Patel, F. Lesage, M. Lazdunski, and E. Honore Mechano- or acid stimulation, two interactive modes of activation of the TREK-1 potassium channel J. Biol. Chem. 274 1999 26691 26696
268. M. Fink, F. Lesage, F. Duprat, C. Heurteaux, R. Reyes, M. Fosset, and M. Lazdunski A neuronal two P domain K + channel stimulated by arachidonic acid and polyunsaturated fatty acids EMBO J. 17 1998 3297 3308
269. F. Maingret, E. Honore, M. Lazdunski, and A.J. Patel Molecular basis of the voltage-dependent gating of TREK-1, a mechano-sensitive K(+) channel Biochem. Biophys. Res. Commun. 292 2002 339 346
270. D. Bockenhauer, N. Zilberberg, and S.A. Goldstein KCNK2: reversible conversion of a hippocampal potassium leak into a voltage-dependent channel Nat. Neurosci. 4 2001 486 491
271. H. Liu, J.A. Enyeart, and J.J. Enyeart Potent inhibition of native TREK-1 K + channels by selected dihydropyridine Ca2 + channel antagonists J. Pharmacol. Exp. Ther. 323 2007 39 48
272. J.J. Enyeart, L. Xu, S. Danthi, and J.A. Enyeart An ACTH- and ATP-regulated background K + channel in adrenocortical cells is TREK-1 J. Biol. Chem. 277 2002 49186 49199
273. E. Honore, F. Maingret, M. Lazdunski, and A.J. Patel An intracellular proton sensor commands lipid- and mechano-gating of the K(+) channel TREK-1 EMBO J. 21 2002 2968 2976
274. F. Lang, M. Foller, K.S. Lang, P.A. Lang, M. Ritter, E. Gulbins, A. Vereninov, and S.M. Huber Ion channels in cell proliferation and apoptotic cell death J. Membr. Biol. 205 2005 147 157
275. S. Ohya, K. Kimura, S. Niwa, A. Ohno, Y. Kojima, S. Sasaki, K. Kohri, and Y. Imaizumi Malignancy grade-dependent expression of K +-channel subtypes in human prostate cancer J. Pharmacol. Sci. 109 2009 148 151
276. A. Innamaa, L. Jackson, V. Asher, G. van Schalkwyk, A. Warren, A. Keightley, D. Hay, A. Bali, H. Sowter, and R. Khan Expression and effects of modulation of the K2P potassium channels TREK-1 (KCNK2) and TREK-2 (KCNK10) in the normal human ovary and epithelial ovarian cancer Clin. Transl. Oncol. 15 2013 910 918
277. D. Ricard, A. Idbaih, F. Ducray, M. Lahutte, K. Hoang-Xuan, and J.Y. Delattre Primary brain tumours in adults Lancet 379 2012 1984 1996
278. J.F. Whitfield, R.P. Bird, B.R. Chakravarthy, R.J. Isaacs, and P. Morley Calcium-cell cycle regulator, differentiator, killer, chemopreventor, and maybe, tumor promoter J. Cell. Biochem. Suppl. 22 1995 74 91
279. L. Santella, K. Kyozuka, L. De Riso, and E. Carafoli Calcium, protease action, and the regulation of the cell cycle Cell Calcium 23 1998 123 130
280. M. Yang, and W.J. Brackenbury Membrane potential and cancer progression Front. Physiol. 4 2013 185
281. B. Rouzaire-Dubois, and J.M. Dubois K + channel block-induced mammalian neuroblastoma cell swelling: a possible mechanism to influence proliferation J. Physiol. 510 Pt 1 1998 93 102
282. B. Rouzaire-Dubois, J.B. Milandri, S. Bostel, and J.M. Dubois Control of cell proliferation by cell volume alterations in rat C6 glioma cells Pflugers Arch. 440 2000 881 888
283. A. Arcangeli Ion channels and transporters in cancer. 3. Ion channels in the tumor cell-microenvironment cross talk Am. J. Physiol. Cell Physiol. 301 2011 C762 C771
284. M. Hammadi, V. Chopin, F. Matifat, I. Dhennin-Duthille, M. Chasseraud, H. Sevestre, and H. Ouadid-Ahidouch Human ether a-gogo K(+) channel 1 (hEag1) regulates MDA-MB-231 breast cancer cell migration through Orai1-dependent calcium entry J. Cell. Physiol. 227 2012 3837 3846
285. M. Brevet, D. Fucks, D. Chatelain, J.M. Regimbeau, R. Delcenserie, H. Sevestre, and H. Ouadid-Ahidouch Deregulation of 2 potassium channels in pancreas adenocarcinomas: implication of KV1.3 gene promoter methylation Pancreas 38 2009 649 654
286. M.S. Cicek, D.C. Koestler, B.L. Fridley, K.R. Kalli, S.M. Armasu, M.C. Larson, C. Wang, S.J. Winham, R.A. Vierkant, D.N. Rider, M.S. Block, B. Klotzle, G. Konecny, B.J. Winterhoff, H. Hamidi, V. Shridhar, J.B. Fan, D.W. Visscher, J.E. Olson, L.C. Hartmann, M. Bibikova, J. Chien, J.M. Cunningham, and E.L. Goode Epigenome-wide ovarian cancer analysis identifies a methylation profile differentiating clear-cell histology with epigenetic silencing of the HERG K + channel Hum. Mol. Genet. 22 2013 3038 3047